INSIGHTS ON DRUG DEVELOPMENT

• A Comparison To Traditional Clone Screening Platforms

  See how 46 CHO clones performed across automated, deep-well, and microbioreactor fed-batch cultures, using cell density, viability, and IgG concentration to evaluate clone performance.

• Eliminate Risk From Your Viral Vector Tech Transfers

  Explore strategies to simplify viral vector tech transfers, reduce risk, and maintain quality under tight timelines, as well as a case study that demonstrates how to streamline this critical process.

• Simplify And Streamline Method Development With In Silico Modeling

  Automated screening paired with in silico modeling can cut method development time while improving robustness. See how combining experimentation and simulation enables faster decision‑making.

• The Complete Guide To Immunohistochemistry

  Immunohistochemistry (IHC) is a tool for visualizing the distribution and localization of antigens within tissue sections. Learn about IHC sample preparation, detection and amplification systems, and more.

• A Scientist's Perspective: Minimizing Hands-On Time In Molecular Assays

  3/26/2026

  Autonomous digital PCR provides absolute quantification in complex matrices. Achieve five-color multiplexing and streamlined data collection without standard curves to accelerate synthetic biology.

• Unlocking The Next Wave Of Cancer Vaccines

  4/21/2026

  Discover how advanced ionizable LNP formulations and scalable manufacturing strategies can accelerate the development and clinical translation of personalized cancer vaccines.

• Five Practical Considerations To Move From Concept To Clinic

  12/17/2025

  Learn more about five key factors for advancing targeted in vivo LNP programs, from formulation and targeting strategies to bioanalytical readiness and scalability.

• Direct Amplification Of Cell Culture Samples

  6/15/2026

  Skip extraction and move straight to amplification with a streamlined qPCR workflow. Achieve comparable performance across multiple targets while reducing costs and saving time.

• Right From The Start: Smarter Developability For Stronger Formulations

  2/4/2026

  Early developability assessment integrates manufacturability, QbD, flexible formulations, and CDMO support to cut risk, speed development, and enable scalable, robust drugs.